U.S. markets open in 8 hours 16 minutes

EC Healthcare (2138.HK)

HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
7.750-0.060 (-0.77%)
As of 11:54AM HKT. Market open.
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close7.810
Bid7.750 x 0
Ask7.760 x 0
Day's Range7.680 - 7.910
52 Week Range5.800 - 16.260
Avg. Volume1,088,760
Market Cap9.132B
Beta (5Y Monthly)1.24
PE Ratio (TTM)27.68
EPS (TTM)0.280
Earnings DateJun 29, 2020
Forward Dividend & Yield0.14 (1.82%)
Ex-Dividend DateSep 05, 2022
1y Target Est13.68
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for 2138.HK

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • PR Newswire

      EC Healthcare and Prenetics Form Strategic Partnership to Pioneer the Future of Medicine

      EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong, announces that the Group signed a memorandum of understanding with Prenetics Limited ("Prenetics") for a strategic collaboration in relation to the formation of a "Healthomics partnership". The partnership will be focused on assembling health data resources from ECH and innovative genetics and diagnostic testing services fr